CrushSCI.com
114.6平均天数
97中位天数
34最短天数
269最长天数
1412025发文量

Paper Review Records

全部论文审稿周期

23 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

91 天

Factors associated with rapid initiation of combination antiretroviral therapy among people living with HIV from 2016 to 2025 in Wuhan, Hubei, China: a decade-long retrospective cross-sectional study

作者
Han Yan; Xuejiao Hu; Xiaoning Li; Rong Hu; Cong Liu; Hongfei Ma; Xiaobing Yang展开收起
作者单位
1. Department of Food Safety and Nutrition Hygiene, Wuhan Center for Disease control and Prevention, Wuhan, China; 2. Department of AIDS Prevention, Wuhan Center for Disease control and Prevention, Wuhan, China; 3. Department of Quality Management, Wuhan Center for Disease control and Prevention, Wuhan, China展开收起
PDF源文件 DOI 网页
111 天

Social determinants, risk behaviors, and mental health comorbidities in relation to treatment adherence and health-promoting lifestyle among people living with HIV in southeast Iran: a cross-sectional correlational study

作者
Hossein Izadira; Gholamreza Masoudy; Mohammad Sedigh Mohammadi; Mehdi Zanganeh Baygi展开收起
作者单位
1. Research Center, Zahedan University of Medical Sciences, Zahedan, Iran展开收起
PDF源文件 DOI 网页
182 天

Brief communication: hepatitis B, human papillomavirus, pneumococcal and influenza vaccination in an Australian metropolitan HIV service

作者
Sophie Sparkes; Nicholas Leedman; Michael Taggart展开收起
作者单位
1. Department of Immunology, Sir Charles Gairdner Hospital, Nedlands, Australia; 2. Department of Immunology, Royal Perth Hospital, Perth, Australia; 3. Department of Infectious Diseases, Royal Perth Hospital, Perth , Australia; 4. Medical School, Faculty of Health and Medical Sciences, The University of Western Australia, Crawley, Australia展开收起
PDF源文件 DOI 网页
269 天

Clinical monitoring for people with HIV and serological evidence of HBV exposure in the era of anti-retroviral therapy without hepatitis B active agents

作者
Jessica Hinh; Karif Hung; Ian Woolley; Sushena Krishnaswamy展开收起
作者单位
1. Monash Infectious Diseases, Monash Health, Melbourne, Australia; 2. School of Clinical Sciences, Monash University, Melbourne, Australia展开收起
PDF源文件 DOI 网页
64 天

B/F/TAF in people with both HIV-1 and hepatitis B: outcomes from the ALLIANCE open-label extension phase

作者
Anchalee Avihingsanon; Chee Loon Leong; Chien-Ching Hung; Sasisopin Kiertiburanakul; Man-Po Lee; Michelle L. D’Antoni; Sharline Madera; Hongyuan Wang; Jason T. Hindman; Taisheng Li展开收起
作者单位
1. HIV-NAT, Thai Red Cross AIDS and Infectious Diseases Research Centre, Bangkok, Thailand; 2. Center of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; 3. Department of Medicine, Kuala Lumpur General Hospital, Kuala Lumpur, Malaysia; 4. Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan; 5. Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; 6. Department of Tropical Medicine and Parasitology, National Taiwan University College of Medicine, Taipei, Taiwan; 7. Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; 8. Department of Medicine, Queen Elizabeth Hospital, Kowloon, China; 9. Clinical Virology, Gilead Sciences, Inc., Foster City, USA; 10. Clinical Development, Gilead Sciences, Inc., Foster City, USA; 11. Biostatistics, Gilead Sciences, Inc., Foster City, USA; 12. Department of Infectious Disease, Peking Union Medical College Hospital, Beijing, China展开收起
PDF源文件 DOI 网页
119 天

People with HIV on antiretroviral therapy demonstrate robust humoral response to influenza vaccination

作者
Preeti Moar; Pauline A. Ocaya; Christoffer Granvik; Julia Wigren Byström; Koushikul Islam; Niklas Arnberg; Therese Thunberg; Mattias N. E. Forsell展开收起
作者单位
1. Department of Clinical Microbiology, Umeå University, Umeå, Sweden; 2. Department of Infectious Diseases, Sundsvall Hospital, Sundsvall, Sweden; 3. Science for Life Laboratory, Department of Clinical Microbiology, Umeå University, Umeå, Sweden展开收起
PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。